nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—TYRO3—connective tissue—celiac disease	0.00297	0.00626	CbGeAlD
Crizotinib—LIMK1—blood—celiac disease	0.00296	0.00625	CbGeAlD
Crizotinib—BLK—lymphoid tissue—celiac disease	0.00296	0.00625	CbGeAlD
Crizotinib—LYN—connective tissue—celiac disease	0.00295	0.00623	CbGeAlD
Crizotinib—PRKD3—blood—celiac disease	0.00289	0.00609	CbGeAlD
Crizotinib—IGF1R—connective tissue—celiac disease	0.00285	0.00602	CbGeAlD
Crizotinib—ACVR1B—pancreas—celiac disease	0.00284	0.00599	CbGeAlD
Crizotinib—MAPK7—lymphoid tissue—celiac disease	0.00283	0.00598	CbGeAlD
Crizotinib—TXK—lymphoid tissue—celiac disease	0.00283	0.00598	CbGeAlD
Crizotinib—BLK—blood—celiac disease	0.00279	0.00588	CbGeAlD
Crizotinib—BMPR1B—epithelium—celiac disease	0.00276	0.00583	CbGeAlD
Crizotinib—IGF1R—epithelium—celiac disease	0.00271	0.00571	CbGeAlD
Crizotinib—TESK1—connective tissue—celiac disease	0.00268	0.00566	CbGeAlD
Crizotinib—MAPK7—blood—celiac disease	0.00267	0.00563	CbGeAlD
Crizotinib—TXK—blood—celiac disease	0.00267	0.00563	CbGeAlD
Crizotinib—MET—lymphoid tissue—celiac disease	0.00265	0.0056	CbGeAlD
Crizotinib—FES—blood—celiac disease	0.00264	0.00557	CbGeAlD
Crizotinib—TIE1—epithelium—celiac disease	0.00263	0.00556	CbGeAlD
Crizotinib—MET—digestive system—celiac disease	0.00262	0.00553	CbGeAlD
Crizotinib—IGF1R—smooth muscle tissue—celiac disease	0.00261	0.00551	CbGeAlD
Crizotinib—NEK9—liver—celiac disease	0.00258	0.00544	CbGeAlD
Crizotinib—CDK7—lymphoid tissue—celiac disease	0.00257	0.00542	CbGeAlD
Crizotinib—TIE1—smooth muscle tissue—celiac disease	0.00254	0.00536	CbGeAlD
Crizotinib—FLT3—connective tissue—celiac disease	0.00252	0.00533	CbGeAlD
Crizotinib—ACVR1—connective tissue—celiac disease	0.00252	0.00533	CbGeAlD
Crizotinib—MET—blood—celiac disease	0.0025	0.00527	CbGeAlD
Crizotinib—IGF1R—pancreas—celiac disease	0.00241	0.00509	CbGeAlD
Crizotinib—TAOK2—blood—celiac disease	0.0024	0.00506	CbGeAlD
Crizotinib—BMP2K—connective tissue—celiac disease	0.00238	0.00502	CbGeAlD
Crizotinib—JAK3—lymphoid tissue—celiac disease	0.00234	0.00494	CbGeAlD
Crizotinib—SIK2—liver—celiac disease	0.00232	0.00489	CbGeAlD
Crizotinib—JAK3—digestive system—celiac disease	0.00231	0.00488	CbGeAlD
Crizotinib—PLK4—lymphoid tissue—celiac disease	0.00231	0.00488	CbGeAlD
Crizotinib—PTK2B—connective tissue—celiac disease	0.0023	0.00485	CbGeAlD
Crizotinib—DCLK1—digestive system—celiac disease	0.0023	0.00485	CbGeAlD
Crizotinib—STK4—lymphoid tissue—celiac disease	0.0023	0.00485	CbGeAlD
Crizotinib—RIPK2—connective tissue—celiac disease	0.00228	0.00481	CbGeAlD
Crizotinib—STK4—digestive system—celiac disease	0.00227	0.00479	CbGeAlD
Crizotinib—PRKD3—liver—celiac disease	0.00226	0.00476	CbGeAlD
Crizotinib—JAK3—blood—celiac disease	0.0022	0.00465	CbGeAlD
Crizotinib—PLK4—blood—celiac disease	0.00217	0.00459	CbGeAlD
Crizotinib—FER—lymphoid tissue—celiac disease	0.00217	0.00458	CbGeAlD
Crizotinib—ALK—lymphoid tissue—celiac disease	0.00217	0.00458	CbGeAlD
Crizotinib—TYRO3—lymphoid tissue—celiac disease	0.00217	0.00458	CbGeAlD
Crizotinib—RIPK2—epithelium—celiac disease	0.00216	0.00457	CbGeAlD
Crizotinib—MAP3K2—connective tissue—celiac disease	0.00216	0.00456	CbGeAlD
Crizotinib—STK4—blood—celiac disease	0.00216	0.00456	CbGeAlD
Crizotinib—LYN—lymphoid tissue—celiac disease	0.00216	0.00456	CbGeAlD
Crizotinib—CASK—liver—celiac disease	0.00215	0.00454	CbGeAlD
Crizotinib—NUAK2—pancreas—celiac disease	0.00215	0.00454	CbGeAlD
Crizotinib—EPHA5—digestive system—celiac disease	0.00214	0.00452	CbGeAlD
Crizotinib—ALK—digestive system—celiac disease	0.00214	0.00452	CbGeAlD
Crizotinib—ACVR1—pancreas—celiac disease	0.00213	0.0045	CbGeAlD
Crizotinib—MAP4K1—lymphoid tissue—celiac disease	0.00213	0.00449	CbGeAlD
Crizotinib—PTK2—connective tissue—celiac disease	0.00212	0.00447	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—celiac disease	0.0021	0.00444	CbGeAlD
Crizotinib—TYK2—connective tissue—celiac disease	0.0021	0.00444	CbGeAlD
Crizotinib—STK35—pancreas—celiac disease	0.00209	0.00441	CbGeAlD
Crizotinib—IGF1R—lymphoid tissue—celiac disease	0.00209	0.0044	CbGeAlD
Crizotinib—FES—liver—celiac disease	0.00206	0.00436	CbGeAlD
Crizotinib—IGF1R—digestive system—celiac disease	0.00206	0.00435	CbGeAlD
Crizotinib—MAP4K2—lymphoid tissue—celiac disease	0.00206	0.00434	CbGeAlD
Crizotinib—ALK—blood—celiac disease	0.00204	0.00431	CbGeAlD
Crizotinib—FER—blood—celiac disease	0.00204	0.00431	CbGeAlD
Crizotinib—RPS6KB1—connective tissue—celiac disease	0.00204	0.0043	CbGeAlD
Crizotinib—LYN—blood—celiac disease	0.00203	0.00429	CbGeAlD
Crizotinib—TNK1—blood—celiac disease	0.00202	0.00427	CbGeAlD
Crizotinib—AXL—connective tissue—celiac disease	0.00202	0.00425	CbGeAlD
Crizotinib—PTK2—epithelium—celiac disease	0.00201	0.00424	CbGeAlD
Crizotinib—MAP4K1—blood—celiac disease	0.002	0.00422	CbGeAlD
Crizotinib—AURKA—lymphoid tissue—celiac disease	0.00198	0.00417	CbGeAlD
Crizotinib—IGF1R—blood—celiac disease	0.00196	0.00414	CbGeAlD
Crizotinib—AURKA—digestive system—celiac disease	0.00195	0.00412	CbGeAlD
Crizotinib—MET—liver—celiac disease	0.00195	0.00412	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—celiac disease	0.00194	0.00409	CbGeAlD
Crizotinib—MAP4K2—blood—celiac disease	0.00194	0.00408	CbGeAlD
Crizotinib—RPS6KB1—epithelium—celiac disease	0.00193	0.00408	CbGeAlD
Crizotinib—EPHB4—connective tissue—celiac disease	0.00193	0.00406	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—celiac disease	0.00192	0.00406	CbGeAlD
Crizotinib—JAK2—connective tissue—celiac disease	0.00191	0.00404	CbGeAlD
Crizotinib—STK3—blood—celiac disease	0.00191	0.00403	CbGeAlD
Crizotinib—MERTK—lymphoid tissue—celiac disease	0.00191	0.00402	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—celiac disease	0.0019	0.00401	CbGeAlD
Crizotinib—CDK7—liver—celiac disease	0.00189	0.00398	CbGeAlD
Crizotinib—TAOK2—liver—celiac disease	0.00187	0.00395	CbGeAlD
Crizotinib—LIMK2—lymphoid tissue—celiac disease	0.00187	0.00394	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—celiac disease	0.00186	0.00393	CbGeAlD
Crizotinib—AURKA—blood—celiac disease	0.00186	0.00393	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—celiac disease	0.00185	0.00389	CbGeAlD
Crizotinib—TESK1—blood—celiac disease	0.00185	0.00389	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—celiac disease	0.00184	0.00389	CbGeAlD
Crizotinib—TEK—connective tissue—celiac disease	0.00184	0.00389	CbGeAlD
Crizotinib—CYP3A4—urine—celiac disease	0.00184	0.00388	CbGeAlD
Crizotinib—EPHB4—epithelium—celiac disease	0.00183	0.00386	CbGeAlD
Crizotinib—JAK2—epithelium—celiac disease	0.00182	0.00383	CbGeAlD
Crizotinib—ACVR1B—liver—celiac disease	0.0018	0.00381	CbGeAlD
Crizotinib—MERTK—blood—celiac disease	0.00179	0.00379	CbGeAlD
Crizotinib—EPHA2—epithelium—celiac disease	0.00179	0.00379	CbGeAlD
Crizotinib—TBK1—pancreas—celiac disease	0.00179	0.00378	CbGeAlD
Crizotinib—PTK2—pancreas—celiac disease	0.00179	0.00378	CbGeAlD
Crizotinib—TYK2—pancreas—celiac disease	0.00178	0.00375	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—celiac disease	0.00176	0.00372	CbGeAlD
Crizotinib—LIMK2—blood—celiac disease	0.00176	0.0037	CbGeAlD
Crizotinib—IRAK1—pancreas—celiac disease	0.00175	0.0037	CbGeAlD
Crizotinib—TEK—epithelium—celiac disease	0.00175	0.00369	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—celiac disease	0.00175	0.00369	CbGeAlD
Crizotinib—NUAK2—blood—celiac disease	0.00175	0.00369	CbGeAlD
Crizotinib—MAP3K12—blood—celiac disease	0.00174	0.00366	CbGeAlD
Crizotinib—ACVR1—blood—celiac disease	0.00174	0.00366	CbGeAlD
Crizotinib—FLT3—blood—celiac disease	0.00174	0.00366	CbGeAlD
Crizotinib—RPS6KB1—pancreas—celiac disease	0.00172	0.00363	CbGeAlD
Crizotinib—YES1—connective tissue—celiac disease	0.0017	0.00359	CbGeAlD
Crizotinib—STK4—liver—celiac disease	0.00169	0.00357	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—celiac disease	0.00169	0.00356	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—celiac disease	0.00169	0.00356	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—celiac disease	0.00168	0.00355	CbGeAlD
Crizotinib—TAOK3—connective tissue—celiac disease	0.00168	0.00355	CbGeAlD
Crizotinib—PTK2B—digestive system—celiac disease	0.00166	0.0035	CbGeAlD
Crizotinib—ABL2—blood—celiac disease	0.00166	0.0035	CbGeAlD
Crizotinib—RIPK2—digestive system—celiac disease	0.00165	0.00347	CbGeAlD
Crizotinib—SLK—pancreas—celiac disease	0.00164	0.00346	CbGeAlD
Crizotinib—SRC—connective tissue—celiac disease	0.00164	0.00346	CbGeAlD
Crizotinib—BMP2K—blood—celiac disease	0.00164	0.00346	CbGeAlD
Crizotinib—EPHB4—pancreas—celiac disease	0.00163	0.00344	CbGeAlD
Crizotinib—EPHA2—pancreas—celiac disease	0.0016	0.00337	CbGeAlD
Crizotinib—FER—liver—celiac disease	0.0016	0.00337	CbGeAlD
Crizotinib—LYN—liver—celiac disease	0.00159	0.00335	CbGeAlD
Crizotinib—PTK2B—blood—celiac disease	0.00158	0.00334	CbGeAlD
Crizotinib—TNK1—liver—celiac disease	0.00158	0.00334	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—celiac disease	0.00158	0.00333	CbGeAlD
Crizotinib—RIPK2—blood—celiac disease	0.00157	0.00331	CbGeAlD
Crizotinib—MAP4K5—pancreas—celiac disease	0.00156	0.00329	CbGeAlD
Crizotinib—TEK—pancreas—celiac disease	0.00156	0.00329	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—celiac disease	0.00156	0.00329	CbGeAlD
Crizotinib—SRC—epithelium—celiac disease	0.00156	0.00328	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—celiac disease	0.00155	0.00327	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—celiac disease	0.00155	0.00327	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—celiac disease	0.00154	0.00324	CbGeAlD
Crizotinib—IGF1R—liver—celiac disease	0.00153	0.00324	CbGeAlD
Crizotinib—TNK2—liver—celiac disease	0.00153	0.00324	CbGeAlD
Crizotinib—PTK2—digestive system—celiac disease	0.00153	0.00323	CbGeAlD
Crizotinib—TBK1—digestive system—celiac disease	0.00153	0.00323	CbGeAlD
Crizotinib—TYK2—digestive system—celiac disease	0.00152	0.0032	CbGeAlD
Crizotinib—EPHA4—blood—celiac disease	0.00152	0.0032	CbGeAlD
Crizotinib—MAP4K2—liver—celiac disease	0.00151	0.00319	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—celiac disease	0.0015	0.00316	CbGeAlD
Crizotinib—STK3—liver—celiac disease	0.00149	0.00315	CbGeAlD
Crizotinib—TIE1—liver—celiac disease	0.00149	0.00315	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—celiac disease	0.00149	0.00314	CbGeAlD
Crizotinib—MAP3K2—blood—celiac disease	0.00149	0.00314	CbGeAlD
Crizotinib—FGR—lymphoid tissue—celiac disease	0.00148	0.00312	CbGeAlD
Crizotinib—AXL—lymphoid tissue—celiac disease	0.00147	0.00311	CbGeAlD
Crizotinib—RPS6KB1—digestive system—celiac disease	0.00147	0.0031	CbGeAlD
Crizotinib—CSF1R—connective tissue—celiac disease	0.00147	0.0031	CbGeAlD
Crizotinib—FGR—digestive system—celiac disease	0.00146	0.00308	CbGeAlD
Crizotinib—PTK2—blood—celiac disease	0.00146	0.00307	CbGeAlD
Crizotinib—TBK1—blood—celiac disease	0.00146	0.00307	CbGeAlD
Crizotinib—AURKA—liver—celiac disease	0.00145	0.00307	CbGeAlD
Crizotinib—TYK2—blood—celiac disease	0.00145	0.00305	CbGeAlD
Crizotinib—TESK1—liver—celiac disease	0.00144	0.00304	CbGeAlD
Crizotinib—YES1—pancreas—celiac disease	0.00144	0.00304	CbGeAlD
Crizotinib—IRAK1—blood—celiac disease	0.00143	0.00301	CbGeAlD
Crizotinib—TAOK3—pancreas—celiac disease	0.00142	0.003	CbGeAlD
Crizotinib—MERTK—liver—celiac disease	0.0014	0.00296	CbGeAlD
Crizotinib—RPS6KB1—blood—celiac disease	0.0014	0.00296	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—celiac disease	0.0014	0.00295	CbGeAlD
Crizotinib—LCK—blood—celiac disease	0.00139	0.00294	CbGeAlD
Crizotinib—FGR—blood—celiac disease	0.00139	0.00294	CbGeAlD
Crizotinib—EPHB4—digestive system—celiac disease	0.00139	0.00294	CbGeAlD
Crizotinib—SRC—pancreas—celiac disease	0.00139	0.00292	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—celiac disease	0.00138	0.00292	CbGeAlD
Crizotinib—JAK2—digestive system—celiac disease	0.00138	0.00292	CbGeAlD
Crizotinib—LIMK2—liver—celiac disease	0.00137	0.0029	CbGeAlD
Crizotinib—NUAK2—liver—celiac disease	0.00137	0.00289	CbGeAlD
Crizotinib—EPHA2—digestive system—celiac disease	0.00136	0.00288	CbGeAlD
Crizotinib—ACVR1—liver—celiac disease	0.00136	0.00287	CbGeAlD
Crizotinib—MAP3K12—liver—celiac disease	0.00136	0.00287	CbGeAlD
Crizotinib—FLT3—liver—celiac disease	0.00136	0.00287	CbGeAlD
Crizotinib—TEK—lymphoid tissue—celiac disease	0.00135	0.00284	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—celiac disease	0.00135	0.00284	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—celiac disease	0.00135	0.00284	CbGeAlD
Crizotinib—SLK—blood—celiac disease	0.00134	0.00282	CbGeAlD
Crizotinib—STK35—liver—celiac disease	0.00133	0.00281	CbGeAlD
Crizotinib—EPHB4—blood—celiac disease	0.00133	0.0028	CbGeAlD
Crizotinib—JAK2—blood—celiac disease	0.00132	0.00278	CbGeAlD
Crizotinib—EPHA2—blood—celiac disease	0.0013	0.00274	CbGeAlD
Crizotinib—ABL2—liver—celiac disease	0.0013	0.00274	CbGeAlD
Crizotinib—BMP2K—liver—celiac disease	0.00128	0.0027	CbGeAlD
Crizotinib—TEK—blood—celiac disease	0.00127	0.00268	CbGeAlD
Crizotinib—MAP3K3—blood—celiac disease	0.00127	0.00268	CbGeAlD
Crizotinib—MAP4K5—blood—celiac disease	0.00127	0.00268	CbGeAlD
Crizotinib—YES1—lymphoid tissue—celiac disease	0.00125	0.00263	CbGeAlD
Crizotinib—PTK2B—liver—celiac disease	0.00124	0.00261	CbGeAlD
Crizotinib—STK10—lymphoid tissue—celiac disease	0.00123	0.0026	CbGeAlD
Crizotinib—YES1—digestive system—celiac disease	0.00123	0.00259	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—celiac disease	0.00123	0.00259	CbGeAlD
Crizotinib—RIPK2—liver—celiac disease	0.00123	0.00259	CbGeAlD
Crizotinib—STK10—digestive system—celiac disease	0.00122	0.00257	CbGeAlD
Crizotinib—TAOK3—digestive system—celiac disease	0.00121	0.00256	CbGeAlD
Crizotinib—EPHB6—blood—celiac disease	0.00121	0.00256	CbGeAlD
Crizotinib—SRC—lymphoid tissue—celiac disease	0.0012	0.00253	CbGeAlD
Crizotinib—SRC—digestive system—celiac disease	0.00118	0.0025	CbGeAlD
Crizotinib—YES1—blood—celiac disease	0.00117	0.00247	CbGeAlD
Crizotinib—MAP3K2—liver—celiac disease	0.00116	0.00245	CbGeAlD
Crizotinib—ABL1—connective tissue—celiac disease	0.00116	0.00245	CbGeAlD
Crizotinib—STK10—blood—celiac disease	0.00116	0.00245	CbGeAlD
Crizotinib—TAOK3—blood—celiac disease	0.00116	0.00244	CbGeAlD
Crizotinib—PTK2—liver—celiac disease	0.00114	0.0024	CbGeAlD
Crizotinib—TBK1—liver—celiac disease	0.00114	0.0024	CbGeAlD
Crizotinib—TYK2—liver—celiac disease	0.00113	0.00239	CbGeAlD
Crizotinib—SRC—blood—celiac disease	0.00113	0.00238	CbGeAlD
Crizotinib—IRAK1—liver—celiac disease	0.00112	0.00236	CbGeAlD
Crizotinib—RPS6KB1—liver—celiac disease	0.0011	0.00231	CbGeAlD
Crizotinib—LCK—liver—celiac disease	0.00109	0.0023	CbGeAlD
Crizotinib—FGR—liver—celiac disease	0.00109	0.0023	CbGeAlD
Crizotinib—AXL—liver—celiac disease	0.00108	0.00229	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—celiac disease	0.00108	0.00227	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—celiac disease	0.00106	0.00224	CbGeAlD
Crizotinib—CSF1R—digestive system—celiac disease	0.00106	0.00224	CbGeAlD
Crizotinib—SLK—liver—celiac disease	0.00104	0.0022	CbGeAlD
Crizotinib—EPHB4—liver—celiac disease	0.00104	0.00219	CbGeAlD
Crizotinib—JAK2—liver—celiac disease	0.00103	0.00217	CbGeAlD
Crizotinib—EPHA2—liver—celiac disease	0.00102	0.00215	CbGeAlD
Crizotinib—CSF1R—blood—celiac disease	0.00101	0.00214	CbGeAlD
Crizotinib—MAP3K3—liver—celiac disease	0.000992	0.00209	CbGeAlD
Crizotinib—TEK—liver—celiac disease	0.000992	0.00209	CbGeAlD
Crizotinib—MAP4K5—liver—celiac disease	0.000992	0.00209	CbGeAlD
Crizotinib—ABL1—pancreas—celiac disease	0.000983	0.00207	CbGeAlD
Crizotinib—YES1—liver—celiac disease	0.000916	0.00193	CbGeAlD
Crizotinib—STK10—liver—celiac disease	0.000908	0.00192	CbGeAlD
Crizotinib—TAOK3—liver—celiac disease	0.000904	0.00191	CbGeAlD
Crizotinib—SRC—liver—celiac disease	0.000881	0.00186	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—celiac disease	0.00085	0.00179	CbGeAlD
Crizotinib—ABL1—digestive system—celiac disease	0.00084	0.00177	CbGeAlD
Crizotinib—ABL1—blood—celiac disease	0.0008	0.00169	CbGeAlD
Crizotinib—CSF1R—liver—celiac disease	0.000791	0.00167	CbGeAlD
Crizotinib—ABL1—liver—celiac disease	0.000625	0.00132	CbGeAlD
Crizotinib—CYP3A5—pancreas—celiac disease	0.000575	0.00121	CbGeAlD
Crizotinib—CYP3A5—digestive system—celiac disease	0.000491	0.00104	CbGeAlD
Crizotinib—CYP3A5—blood—celiac disease	0.000468	0.000988	CbGeAlD
Crizotinib—CYP3A4—digestive system—celiac disease	0.000369	0.000778	CbGeAlD
Crizotinib—CYP3A5—liver—celiac disease	0.000366	0.000773	CbGeAlD
Crizotinib—CYP3A4—blood—celiac disease	0.000351	0.000741	CbGeAlD
Crizotinib—ABCB1—epithelium—celiac disease	0.000343	0.000724	CbGeAlD
Crizotinib—ABCB1—pancreas—celiac disease	0.000306	0.000645	CbGeAlD
Crizotinib—CYP3A4—liver—celiac disease	0.000275	0.00058	CbGeAlD
Crizotinib—ABCB1—lymphoid tissue—celiac disease	0.000264	0.000558	CbGeAlD
Crizotinib—ABCB1—digestive system—celiac disease	0.000261	0.000551	CbGeAlD
Crizotinib—ABCB1—blood—celiac disease	0.000249	0.000525	CbGeAlD
Crizotinib—ABCB1—liver—celiac disease	0.000195	0.00041	CbGeAlD
Crizotinib—LCK—Adaptive Immune System—HLA-DPB1—celiac disease	6.69e-05	0.000127	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MYO9B—celiac disease	6.67e-05	0.000127	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CCR3—celiac disease	6.65e-05	0.000126	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DPB1—celiac disease	6.64e-05	0.000126	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DQB1—celiac disease	6.6e-05	0.000125	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SH2B3—celiac disease	6.58e-05	0.000125	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TAGAP—celiac disease	6.54e-05	0.000124	CbGpPWpGaD
Crizotinib—LYN—Immune System—MBL2—celiac disease	6.53e-05	0.000124	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—CD80—celiac disease	6.53e-05	0.000124	CbGpPWpGaD
Crizotinib—ABL1—Immune System—MBL2—celiac disease	6.5e-05	0.000124	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HLA-DRB1—celiac disease	6.5e-05	0.000124	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SH2B3—celiac disease	6.48e-05	0.000123	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DQB1—celiac disease	6.44e-05	0.000122	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DQB1—celiac disease	6.42e-05	0.000122	CbGpPWpGaD
Crizotinib—LCK—HIV Infection—CD4—celiac disease	6.4e-05	0.000122	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CTLA4—celiac disease	6.38e-05	0.000121	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DQB1—celiac disease	6.37e-05	0.000121	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CCR3—celiac disease	6.37e-05	0.000121	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CTLA4—celiac disease	6.34e-05	0.000121	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—CD80—celiac disease	6.34e-05	0.00012	CbGpPWpGaD
Crizotinib—TBK1—Immune System—HLA-DRB1—celiac disease	6.32e-05	0.00012	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DPB1—celiac disease	6.3e-05	0.00012	CbGpPWpGaD
Crizotinib—YES1—Immune System—CTLA4—celiac disease	6.29e-05	0.00012	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CD8A—celiac disease	6.25e-05	0.000119	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—CD80—celiac disease	6.25e-05	0.000119	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCR4—celiac disease	6.23e-05	0.000118	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SH2B3—celiac disease	6.2e-05	0.000118	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CCR3—celiac disease	6.17e-05	0.000117	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CCR3—celiac disease	6.17e-05	0.000117	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—CD4—celiac disease	6.17e-05	0.000117	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CD8A—celiac disease	6.16e-05	0.000117	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCR4—celiac disease	6.14e-05	0.000117	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DPB1—celiac disease	6.11e-05	0.000116	CbGpPWpGaD
Crizotinib—JAK2—Immune System—MBL2—celiac disease	6.11e-05	0.000116	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD79A—celiac disease	6.09e-05	0.000116	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HLA-DRB1—celiac disease	6.06e-05	0.000115	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD79A—celiac disease	6.05e-05	0.000115	CbGpPWpGaD
Crizotinib—BLK—Immune System—CD8A—celiac disease	6.02e-05	0.000114	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SH2B3—celiac disease	6.02e-05	0.000114	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD79A—celiac disease	6e-05	0.000114	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—CD80—celiac disease	6e-05	0.000114	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—CD4—celiac disease	6e-05	0.000114	CbGpPWpGaD
Crizotinib—FGR—Immune System—CD8A—celiac disease	6e-05	0.000114	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—CD80—celiac disease	5.97e-05	0.000114	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CTLA4—celiac disease	5.97e-05	0.000113	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CD8A—celiac disease	5.95e-05	0.000113	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—CD80—celiac disease	5.93e-05	0.000113	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—CD80—celiac disease	5.93e-05	0.000113	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RGS1—celiac disease	5.93e-05	0.000113	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DPB1—celiac disease	5.92e-05	0.000113	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—CD4—celiac disease	5.92e-05	0.000113	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—CD4—celiac disease	5.91e-05	0.000112	CbGpPWpGaD
Crizotinib—LYN—Immune System—FCGR2A—celiac disease	5.91e-05	0.000112	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LCT—celiac disease	5.91e-05	0.000112	CbGpPWpGaD
Crizotinib—ABL1—Immune System—FCGR2A—celiac disease	5.88e-05	0.000112	CbGpPWpGaD
Crizotinib—TBK1—Immune System—CD80—celiac disease	5.84e-05	0.000111	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCR4—celiac disease	5.83e-05	0.000111	CbGpPWpGaD
Crizotinib—LYN—Immune System—TNFAIP3—celiac disease	5.8e-05	0.00011	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CTLA4—celiac disease	5.79e-05	0.00011	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TAGAP—celiac disease	5.79e-05	0.00011	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TNFAIP3—celiac disease	5.77e-05	0.00011	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—CD80—celiac disease	5.76e-05	0.000109	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-DRB1—celiac disease	5.71e-05	0.000109	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—CD4—celiac disease	5.7e-05	0.000108	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD79A—celiac disease	5.69e-05	0.000108	CbGpPWpGaD
Crizotinib—LYN—Immune System—PTPN2—celiac disease	5.66e-05	0.000108	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCR4—celiac disease	5.66e-05	0.000108	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PTPN2—celiac disease	5.64e-05	0.000107	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQA1—celiac disease	5.62e-05	0.000107	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CTLA4—celiac disease	5.61e-05	0.000107	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—CD80—celiac disease	5.6e-05	0.000106	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQA1—celiac disease	5.58e-05	0.000106	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RGS1—celiac disease	5.55e-05	0.000105	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQA1—celiac disease	5.54e-05	0.000105	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD79A—celiac disease	5.53e-05	0.000105	CbGpPWpGaD
Crizotinib—JAK2—Immune System—FCGR2A—celiac disease	5.53e-05	0.000105	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—CD4—celiac disease	5.45e-05	0.000104	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—CD4—celiac disease	5.45e-05	0.000104	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TNFAIP3—celiac disease	5.43e-05	0.000103	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD79A—celiac disease	5.36e-05	0.000102	CbGpPWpGaD
Crizotinib—LCK—Immune System—MBL2—celiac disease	5.35e-05	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTPN2—celiac disease	5.3e-05	0.000101	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCR3—celiac disease	5.3e-05	0.000101	CbGpPWpGaD
Crizotinib—JAK3—Immune System—CD80—celiac disease	5.28e-05	0.0001	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQA1—celiac disease	5.26e-05	9.99e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQB1—celiac disease	5.26e-05	9.99e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCR3—celiac disease	5.22e-05	9.93e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQB1—celiac disease	5.22e-05	9.93e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—CD80—celiac disease	5.22e-05	9.92e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQB1—celiac disease	5.18e-05	9.85e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SH2B3—celiac disease	5.16e-05	9.81e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQA1—celiac disease	5.1e-05	9.7e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DRB1—celiac disease	5.09e-05	9.68e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SH2B3—celiac disease	5.09e-05	9.68e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DRB1—celiac disease	5.02e-05	9.54e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCR3—celiac disease	4.95e-05	9.42e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DPB1—celiac disease	4.95e-05	9.41e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQA1—celiac disease	4.94e-05	9.4e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DPB1—celiac disease	4.93e-05	9.37e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQB1—celiac disease	4.92e-05	9.34e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD8A—celiac disease	4.91e-05	9.33e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DRB1—celiac disease	4.9e-05	9.31e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DRB1—celiac disease	4.88e-05	9.28e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD8A—celiac disease	4.88e-05	9.27e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RGS1—celiac disease	4.86e-05	9.23e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DRB1—celiac disease	4.84e-05	9.21e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—FCGR2A—celiac disease	4.84e-05	9.2e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD8A—celiac disease	4.84e-05	9.2e-05	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—CD4—celiac disease	4.84e-05	9.2e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SH2B3—celiac disease	4.83e-05	9.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCR3—celiac disease	4.81e-05	9.14e-05	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—CD4—celiac disease	4.77e-05	9.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQB1—celiac disease	4.77e-05	9.07e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—TNFAIP3—celiac disease	4.75e-05	9.03e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—MBL2—celiac disease	4.74e-05	9.01e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CD80—celiac disease	4.72e-05	8.97e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CD80—celiac disease	4.7e-05	8.94e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CTLA4—celiac disease	4.69e-05	8.92e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SH2B3—celiac disease	4.69e-05	8.91e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CTLA4—celiac disease	4.67e-05	8.88e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—CD80—celiac disease	4.66e-05	8.86e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTPN2—celiac disease	4.64e-05	8.82e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—CD80—celiac disease	4.64e-05	8.82e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CD80—celiac disease	4.64e-05	8.81e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DPB1—celiac disease	4.63e-05	8.81e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQB1—celiac disease	4.62e-05	8.79e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CD80—celiac disease	4.62e-05	8.78e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD8A—celiac disease	4.59e-05	8.73e-05	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—CD4—celiac disease	4.58e-05	8.71e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCR4—celiac disease	4.58e-05	8.71e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—CD80—celiac disease	4.55e-05	8.66e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—CD4—celiac disease	4.53e-05	8.6e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—CD80—celiac disease	4.53e-05	8.6e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—CD80—celiac disease	4.51e-05	8.57e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD79A—celiac disease	4.48e-05	8.51e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CD80—celiac disease	4.48e-05	8.51e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—CD4—celiac disease	4.46e-05	8.47e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD79A—celiac disease	4.46e-05	8.47e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD8A—celiac disease	4.46e-05	8.47e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—CD4—celiac disease	4.39e-05	8.35e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CTLA4—celiac disease	4.39e-05	8.35e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—CD80—celiac disease	4.36e-05	8.29e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD8A—celiac disease	4.32e-05	8.21e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RGS1—celiac disease	4.3e-05	8.17e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—FCGR2A—celiac disease	4.29e-05	8.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR4—celiac disease	4.29e-05	8.15e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—CD4—celiac disease	4.27e-05	8.12e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TNFAIP3—celiac disease	4.21e-05	8e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD79A—celiac disease	4.19e-05	7.96e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQA1—celiac disease	4.13e-05	7.85e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQA1—celiac disease	4.11e-05	7.82e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTPN2—celiac disease	4.11e-05	7.81e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DPB1—celiac disease	4.06e-05	7.71e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—CD4—celiac disease	4.03e-05	7.66e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DRB1—celiac disease	4e-05	7.6e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DRB1—celiac disease	3.97e-05	7.55e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DRB1—celiac disease	3.94e-05	7.49e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCR3—celiac disease	3.89e-05	7.4e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQA1—celiac disease	3.87e-05	7.35e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQB1—celiac disease	3.86e-05	7.35e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CTLA4—celiac disease	3.85e-05	7.31e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQB1—celiac disease	3.85e-05	7.31e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CD80—celiac disease	3.82e-05	7.26e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SH2B3—celiac disease	3.8e-05	7.21e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR4—celiac disease	3.75e-05	7.14e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DRB1—celiac disease	3.74e-05	7.1e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD80—celiac disease	3.69e-05	7.02e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD79A—celiac disease	3.67e-05	6.98e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD80—celiac disease	3.67e-05	6.97e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR3—celiac disease	3.64e-05	6.93e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD80—celiac disease	3.64e-05	6.92e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LCT—celiac disease	3.64e-05	6.92e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DRB1—celiac disease	3.63e-05	6.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQB1—celiac disease	3.62e-05	6.87e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD8A—celiac disease	3.61e-05	6.86e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DPB1—celiac disease	3.59e-05	6.83e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD8A—celiac disease	3.59e-05	6.83e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CD4—celiac disease	3.59e-05	6.83e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—CD4—celiac disease	3.56e-05	6.76e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SH2B3—celiac disease	3.55e-05	6.75e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—CD4—celiac disease	3.54e-05	6.73e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CD4—celiac disease	3.54e-05	6.73e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DRB1—celiac disease	3.52e-05	6.68e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—CD4—celiac disease	3.48e-05	6.61e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—CD4—celiac disease	3.46e-05	6.57e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD80—celiac disease	3.45e-05	6.56e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—CD4—celiac disease	3.44e-05	6.55e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CD4—celiac disease	3.42e-05	6.5e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CD80—celiac disease	3.41e-05	6.49e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CTLA4—celiac disease	3.41e-05	6.47e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQA1—celiac disease	3.39e-05	6.44e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CD80—celiac disease	3.38e-05	6.43e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD8A—celiac disease	3.38e-05	6.42e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD80—celiac disease	3.35e-05	6.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—CD4—celiac disease	3.33e-05	6.33e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR4—celiac disease	3.32e-05	6.32e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD79A—celiac disease	3.25e-05	6.17e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD80—celiac disease	3.25e-05	6.17e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR3—celiac disease	3.19e-05	6.07e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQB1—celiac disease	3.17e-05	6.02e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SH2B3—celiac disease	3.11e-05	5.91e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD80—celiac disease	3.1e-05	5.88e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CD80—celiac disease	3.04e-05	5.78e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQA1—celiac disease	3e-05	5.7e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CD80—celiac disease	3e-05	5.7e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD8A—celiac disease	2.96e-05	5.62e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DRB1—celiac disease	2.94e-05	5.59e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DRB1—celiac disease	2.92e-05	5.56e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CD4—celiac disease	2.92e-05	5.54e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CD80—celiac disease	2.87e-05	5.45e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR3—celiac disease	2.83e-05	5.37e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD4—celiac disease	2.82e-05	5.36e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQB1—celiac disease	2.8e-05	5.33e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD4—celiac disease	2.8e-05	5.32e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CD80—celiac disease	2.78e-05	5.29e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD4—celiac disease	2.78e-05	5.28e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SH2B3—celiac disease	2.75e-05	5.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DRB1—celiac disease	2.75e-05	5.23e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD80—celiac disease	2.71e-05	5.16e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD80—celiac disease	2.7e-05	5.14e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD4—celiac disease	2.64e-05	5.01e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD8A—celiac disease	2.62e-05	4.98e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CD4—celiac disease	2.58e-05	4.91e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD4—celiac disease	2.56e-05	4.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD80—celiac disease	2.54e-05	4.83e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD4—celiac disease	2.48e-05	4.71e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DRB1—celiac disease	2.41e-05	4.58e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CD80—celiac disease	2.39e-05	4.54e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD4—celiac disease	2.36e-05	4.49e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CD80—celiac disease	2.35e-05	4.47e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD80—celiac disease	2.35e-05	4.46e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CD80—celiac disease	2.23e-05	4.24e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD80—celiac disease	2.23e-05	4.23e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CD80—celiac disease	2.17e-05	4.12e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—celiac disease	2.13e-05	4.05e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—celiac disease	2.07e-05	3.94e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—celiac disease	2.06e-05	3.92e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD80—celiac disease	2.05e-05	3.91e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD80—celiac disease	1.97e-05	3.74e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—celiac disease	1.94e-05	3.69e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD80—celiac disease	1.82e-05	3.46e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—celiac disease	1.79e-05	3.4e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CD80—celiac disease	1.76e-05	3.34e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—celiac disease	1.7e-05	3.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CD80—celiac disease	1.64e-05	3.12e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—celiac disease	1.57e-05	2.98e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—celiac disease	1.5e-05	2.86e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CD80—celiac disease	1.44e-05	2.73e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—celiac disease	1.39e-05	2.64e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CD80—celiac disease	1.27e-05	2.42e-05	CbGpPWpGaD
